112271 ⎘
Vectors comprising a special origin of replication system from viruses
Binary Self-Amplifying Nucleic Acid Platform and Uses Thereof
#2VECTOR FOR MULTI-GENE BASE EDITING, EDITING METHOD, AND USE
#3MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDS
#4NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS
#5PLASMID DNA CONSTRUCTS FOR THERAPEUTIC PROTEIN EXPRESSION
#6METHODS AND COMPOSITIONS FOR CELLULAR THERAPY
#7IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
#8OPTIMIZED CYP4V2 GENE AND APPLICATION THEREOF
#9DNA VECTORS AND ELEMENTS FOR SUSTAINED GENE EXPRESSION IN EUKARYOTIC CELLS
#10Phagemid Vector
#11ENABLING CHOLESTEROL CATABOLISM IN HUMAN CELLS
#12METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE
#13Restrictive inverted terminal repeats for viral vectors
#14Immunization of large mammals with low doses of RNA
#15Immunisation of large mammals with low doses of RNA
#16Immunisation of large mammals with low doses of RNA
#17Immunisation of large mammals with low doses of RNA
#18Immunisation of large mammals with low doses of RNA
#19METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE
#20METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS BY REPROGRAMMING SOMATIC CELLS
#21PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION
#22GEMINIVIRAL VECTORS THAT REDUCE CELL DEATH AND ENHANCE EXPRESSION OF BIOPHARMACEUTICAL PROTEINS
#23METHOD FOR THE PRODUCTION OF AN ANTIBODY
#24Genetically Engineered Cells and Uses Thereof
#25NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS
#26MODULATION OF REP PROTEIN ACTIVITY IN CLOSED-ENDED DNA (CEDNA) PRODUCTION
#27Immunisation of large mammals with low doses of RNA
#28Control of replication and transcription of self-replicating RNA in response to small molecules
#29Restrictive inverted terminal repeats for viral vectors
#30DNA vectors and elements for sustained gene expression in eukaryotic cells
#31Nanoparticles and biotemplates with tunable length and methods of manufacturing the same
#32Cancer treatment
#33Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#34Compostions and methods for enabling cholesterol catabolism in human cells
#35MICRORNAS FOR TREATMENT OF NEUROPATHIC PAIN
#36Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#37Immunisation of large mammals with low doses of RNA
#38MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDS
#39PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the same
#40METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE
#41Compositions and Methods of Delivering Treatments for Latent Viral Infections
#42Restrictive inverted terminal repeats for viral vectors
#43Compositions and Methods of Delivering Treatments for Latent Viral Infections
#44NON-VIRAL IPSCS INDUCING METHOD, COMPOSITIONS, KITS AND IPSCS
#45NON-VIRAL IPSCS INDUCING METHOD, COMPOSITIONS, KITS AND IPSCS
#46METHODS FOR THE PRODUCTION OF IPS CELLS USING NON-VIRAL APPROACH
#47Phagemid vector
#48Use of microRNAs to control virus helper nucleic acids
#49Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#50Methods and Vectors to Produce Vector Free Induced Pluripotent Stem Cells
#51Methods and materials for obtaining hepatocyte lineage cells
#52Compositions and Methods of Delivering Treatments for Latent Viral Infections
#53METHOD FOR PRODUCING VECTOR IN WHICH FOREIGN GENE HAS BEEN INTRODUCED
#54Serum-free stable transfection and production of recombinant human proteins in human cell lines
#55Restrictive inverted terminal repeats for viral vectors
#56COMPOSITIONS AND METHODS FOR ENGINEERING CELLS
#57Mitochondrial expression vector and method for the transformation of mitochondria
#58Increasing protein yield in plants
#59Use of microRNAs to control virus helper nucleic acids
#60Methods for the production of IPS cells using non-viral approach
#61Methods for the production of IPS cells using Epstein-Barr (EBV)-based reprogramming vectors
#62Immunisation of large mammals with low doses of RNA
#63Restrictive inverted terminal repeats for viral vectors
#64Compositions and Methods for Engineering Cells
#65Use of microRNAs to control virus helper nucleic acids
#66Episomal expression vector for metazoan cells
#67Compositions and Methods for Engineering Cells
#68Immunoglobulin display vectors
#69Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays
#70Serum-free stable transfection and production of recombinant human proteins in human cell lines
#71Purkinje cell-tropic viral vector
#72Methods for the production of iPS cells using non-viral approach
#73Autonomously Replicating KSHV CIS-Acting Elements
#74Efficient /EBNA-1 plasmid vector
#75Immunoglobulin display vectors
#76Herpes Virus-Based Compositions and Methods of Use
#77Methods and materials for expression of a recombinant protein
#78Methods and Materials for Expression of a Recombinant Protein
#79Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression
#80Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof
#81Conditional gene vectors regulated in
#82Alphavirus replicons and helper constructs
#83Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
#84Methods and materials for expression of a recombinant protein
#85Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
#86Marek's disease virus vaccine
#87Immunization of large mammals with low doses of RNA